Evidence map›Paper›PMID 35490233›Full record

ArticleBMC endocrine disorders2022

Fatty liver index for hyperuricemia diagnosis: a community-based cohort study.

Jianchang Qu, Jingtao Dou, Anping Wang, Yingshu Liu, Lu Lin, Kang Chen, Li Zang, Yiming Mu

Open access · goldAbstract read
In one paragraph

Article in BMC endocrine disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Fatty liver index (FLI): more than a marker of hepatic steatosis.Journal of physiology and biochemistry · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jianchang QuMedical School of Chinese PLA, Beijing, China.
Jingtao DouMedical School of Chinese PLA, Beijing, China. jingtaodou@163.com.
Anping WangDepartment of Endocrinology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Yingshu LiuDepartment of Endocrinology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Lu LinDepartment of Endocrinology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Kang ChenDepartment of Endocrinology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Li ZangDepartment of Endocrinology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Yiming MuDepartment of Endocrinology, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China.
Chinese PLA General Hospital · CNPLA 306 Hospital · CNPLA Academy of Military Science · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies have demonstrated the relationship between the fatty liver index (FLI) and metabolism, while few research reported its relationship with hyperuricemia (HUA). This study aimed to predict HUA by determining the relationship between the baseline FLI and HUA events and by validating the FLI-HUA correlation through follow-up.

methodsThis study was a community-based cohort study involving 8851 adults in China. We performed anthropometric assessments and analyzed baseline and follow-up blood samples. HUA was defined as a uric acid level of > 420 µmol/L (7 mg/dL).

resultsPatients with HUA had a higher prevalence of diabetes mellitus, lipid metabolism disorders, and hypertension and higher FLI values than those with normal uric acid levels (P < 0.001). Serum uric acid was positively correlated with the FLI (r = 0.41, P < 0.001); the diagnostic cut-off value of FLI for the diagnosis of HUA was 27.15, with a specificity of 70.9% and sensitivity of 79.6%. FLI was an independent risk factor for HUA, with a 1.72-, 2.74-, and 4.80-fold increase in the risk of developing HUA with increasing FLI quartile levels compared with the FLI at quartile level 1 (P < 0.001). After a mean follow-up of 4 years, as the FLI values increased compared with the FLI at quartile level 1, the risk of new-onset HUA increased by 3.10-, 4.89-, and 6.97-fold (P < 0.001).

conclusionThere is a higher incidence of metabolic abnormalities in HUA populations, and FLI is an independent factor that may contribute to HUA development. Therefore, FLI is a potential tool to predict the risk of developing HUA.

Indexed as

Fatty LiverHyperuricemiaAdultCohort StudiesHumansIncidenceUric AcidUric AcidCommunityFatty liver indexHyperuricemiaMetabolic score for insulin resistanceUric acid

Identifiers

PMID35490233
PMCPMC9055371
OpenAlexW4225150674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.